Biomedical Research Center of the Slovak Academy of Sciences

What Biomedical Research Center of the Slovak Academy of Sciences does

The Biomedical Research Center of the Slovak Academy of Sciences (BMC SAV) is a public research institution (verejná výskumná inštitúcia, v. v. i.) established in 2016 and headquartered in Bratislava, Slovakia, with additional sites in Košice, Šarišské Michaľany, and Ružomberok. It consolidates five research institutes — covering endocrinology, oncology, virology, clinical and translational medicine, and neurobiology — alongside approximately fifteen specialized laboratories, and employs 66 staff. The Center produces peer-reviewed scientific publications, molecular and clinical diagnostics, viral isolate collections, and translational research outputs, and serves the Slovak and broader European healthcare, research, and academic ecosystem, including doctoral students, clinicians, public-health authorities, and industry partners.

Core infrastructure includes BSL-3 containment laboratories, GMP-certified production facilities at the Biomedical Tissue Laboratory (BTL) for cell-based and tissue-engineered products, a National Reference Centre for Rickettsioses and Chlamydioses, and a Bioinformatics Laboratory operating genomic, transcriptomic, metagenomic, and proteomic analysis pipelines. The Center maintains viral isolate repositories linked to the European Virus Archive – GLOBAL and runs disease-focused programs including the DIABGENE diabetes biomarker initiative, multidisciplinary obesity research, COVID-19 epidemiological modeling, and zoonotic pathogen surveillance.

The business model is a non-commercial public-sector research model. Funding derives from Slovak government institutional allocations, EU framework programme grants (Horizon Europe, Horizon 2020, COST Actions), Slovak national grant agencies (VEGA, APVV), and a smaller stream of contract research and GMP-compliant tissue-engineering services enabled by recent certification. The Center's commercial revenue exposure is limited but growing through the GMP-certified BTL pathway; the dominant revenue mechanism remains competitive public grant capture and institutional budget allocation.

Name

Biomedical Research Center of the Slovak Academy of Sciences

Legal name

Biomedicínske centrum Slovenskej akadémie vied, v. v. i.

Website

https://bmc.sav.sk

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Short description

The Biomedical Research Center of the Slovak Academy of Sciences is a public research institution in Bratislava, Slovakia, operating five institutes and roughly 15 specialized laboratories in oncology, endocrinology, virology, neurobiology, and clinical and translational medicine, serving the Slovak and European healthcare and research ecosystem.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical Laboratories (621511)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro industry

PRIMARYEDAHAGAI

Biomedical Sciences & Medical Research Institutes (University-Based)

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

SECONDARYHLAGAEAA

Central Laboratory Services (Core Lab Operations)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

SECONDARYHLAFAMAL

Clinical Research & Trial Central Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

Keywords

• Biomedical research services
• Clinical laboratory diagnostics
• Translational medical research
• Molecular biology research
• Drug discovery research

Headquarters

HQ city

Bratislava

HQ country

Slovakia

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Public Research Funding: As a public research institution under the Slovak Academy of Sciences, the center is primarily funded through government allocations, European Union research programs, and national grant agencies (APVV, VEGA, SRDA). Revenue comes from competitive research grants and project-based funding.
2. Research Services: Provides specialized laboratory services to other scientific institutions, universities, veterinary services, and healthcare providers. Services include DNA diagnostics, bioinformatics analyses, histopathology, and other specialized testing.
3. Educational Programs: Generates revenue through PhD programs, doctoral school, bachelor's and master's thesis supervision, and professional internships.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Biomedical Research Center of the Slovak Academy of Sciences (BMC SAS) conducts fundamental, translational, and clinical biomedical research across endocrinology, oncology, virology, neurobiology, and metabolic disorders. The center operates five research institutes supported by thirteen specialized laboratories and centers, providing diagnostic, analytical, and biopharmaceutical development services to other research institutions, universities, and healthcare providers, while training PhD students and early-career researchers.

Product overview

Biomedical Research Center of the Slovak Academy of Sciences (BMC SAS) is a multi-institute biomedical research organization structured as five core research institutes (Institute of Experimental Endocrinology, Institute of Experimental Oncology, Institute of Virology, Institute of Clinical and Translational Research, and Institute of Neurobiology) supported by a network of approximately 15 specialized laboratories and centers. The specialized units include DIABGENE DNA Diagnostics Laboratory, Center for Physical Activity, Center for Obesity Management, Bioimaging Laboratory, Laboratory of Cytoanalytics, BSL3 Laboratories, Radioisotope Laboratory, Clinical Research Unit, Laboratory of Radiobiology, Laboratory of Bioinformatics, Laboratory of Histopathology, and Biotechnological and Analytical Laboratories (BTL), along with three animal facilities. These units provide research infrastructure, analytical services, and specialized testing capabilities to both internal researchers and external institutions, with some offering services to professionals and the general public.

Differentiator

Problem solved

Functional benefit

Brands

• Centrum pre manažment obezity (Center for Obesity Management): A specialized center providing comprehensive care for obesity patients and conducting research on causes, consequences, and intervention options for obesity. Accredited by the European Association for the Study of Obesity (EASO) in November 2022.
• Centrum pohybovej aktivity (Center for Physical Activity)
• DIABGENE Laboratórium DNA diagnostiky (DIABGENE DNA Diagnostics Laboratory)
• Špecializované laboratóriá (Specialized Laboratories)

Products and services

• Institute of Experimental Endocrinology Research institute within BMC SAS focusing on endocrinology, metabolism, and genetics research, providing basic and translational research capabilities to internal and external collaborators.
• Institute of Experimental Oncology (Cancer Research Institute) Research institute investigating oncology and nanobiology approaches, supporting the Laboratory of Radiobiology and related cancer research programs across Slovakia.
• Institute of Virology Research institute focused on virology, microbiology, and immunology, including work with dangerous pathogens in BSL3 laboratories and operating the European Virus Archive's Slovak operations.
• Institute of Clinical and Translational Research Institute bridging basic research and clinical applications in biomedicine, supporting clinical research unit operations and translational studies.
• Institute of Neurobiology Research institute dedicated to neurobiology research with facilities in Bratislava and Košice, including the Animal Facility for Wistar laboratory rats.
• DIABGENE DNA Diagnostics Laboratory Specialized laboratory managing infrastructure for sequential and functional analyses of nucleic acids, providing diagnostic and consulting services for diabetes, hypoglycemia, hearing impairment, monogenic obesity, and rare disorders. Also offers consulting on nucleic acid study methods, gene structure and expression, and genomic data analysis.
• Center for Obesity Management Specialized center providing comprehensive care for obesity patients and conducting scientific research on causes and consequences of obesity, intervention options, and patient care. EASO-accredited since November 2022.
• Center for Physical Activity Center studying the effects of exercise on health, metabolism, and aging, offering research and advisory services for professionals and the public.
• BSL3 Laboratories High-containment biosafety level 3 laboratories for experimental work with highly dangerous pathogens including tick-borne encephalitis virus, West Nile fever virus, hantaviruses, rickettsiae, and SARS-CoV-2. Houses part of the European Virus Archive operations and includes state-of-the-art animal facilities for small laboratory animals.
• Laboratory of Bioinformatics Laboratory providing expert analyses and consulting for biomedicine research, developing computational tools for processing, analysis, and visualization of biological data including genomic, transcriptomic, and metagenomic datasets. Offers automated pipelines for genetic variant identification, gene expression analysis, and microbiome profiling.
• Biotechnological and Analytical Laboratories (BTL) Laboratories in Šarišské Michaľany focused on developing novel approaches for preparation, formulation, characterization, and analysis of biologically active macromolecules for therapeutic, preventive, and diagnostic purposes. Includes GMP-certified analytical laboratories meeting pharmaceutical industry standards for development of therapeutic biopharmaceuticals from eukaryotic cells, viral vaccines, and substances of bacterial origin.
• Laboratory of Radiobiology Laboratory in Ružomberok studying radiobiological effects of ionizing and non-ionizing radiation, including cancer cell growth inhibition, magnetic field mapping, 5G radiation genotoxicity assessment, and proton therapy research. Located at the Proton Therapy Complex within the Central Military Hospital.
• Laboratory of Histopathology Laboratory processing biological material into cytological and histological specimens, providing diagnostic interpretation, autopsy diagnostics for experimental animals, and accepting material from domestic and foreign institutions including veterinary services of contracted clinics.
• Clinical Research Unit Research clinic providing clinical research services and support for translational research, including clinical studies and trials serving academic and healthcare partners.
• Bioimaging Laboratory Laboratory providing bioimaging services and support for BMC research tasks across endocrinology, oncology, and neurobiology programs.
• Laboratory of Cytoanalytics Laboratory providing cytoanalytical services and research support, including flow cytometry and cellular analysis for research projects across BMC SAS.
• Executive Laboratory of the National Reference Centre for Surveillance and Laboratory Diagnostics of Rickettsioses National reference laboratory providing rickettsiosis surveillance and diagnostic services for public health authorities in Slovakia and neighboring regions.
• Animal Facility for Immunodeficient Mice Facility for breeding and keeping immunodeficient laboratory mice for approved biomedical research procedures, supporting cancer and other research programs across BMC SAS.

Quantifiable outcome

• EASO accreditation for obesity management since November 2022
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Eight partnerships are on record, tiered core.

• Alliance4Life (A4L)coreStrategic or Co-development PartnerAlliance of 12 progressive health research institutions and universities in 11 Central and Eastern European countries, working to bridge the research and innovation gap. BMC SAS participates in A4L_BRIDGE project to implement strategic changes toward enhanced attractiveness, competitiveness, and innovation strength.
• CCI4EU (Comprehensive Cancer Infrastructures for Europe)coreStrategic or Co-development PartnerEuropean initiative to strengthen cancer research infrastructure. Project coordinated by doc. RNDr. Soňa Čierniková, PhD., MPH with duration May 2023 - April 2026.
• ZOE (Zoonoses Emergence across Degraded and Restored Forest Ecosystems)coreStrategic or Co-development PartnerInternational project analyzing links between land-cover changes and zoonotic disease emergence. Coordinated by RNDr. Boris Klempa, DrSc. with partners from 7 EU and 4 American countries.
• European Virus Archive (EVA)coreTechnology or IntegrationEuropean network for virus research and resources. EVA hosts part of its operations at BMC SAS BSL3 laboratories.
• ADDIT-CE (Alzheimer's Disease Diagnostics Innovation and Translation to Clinical Practice in Central Europe)coreStrategic or Co-development PartnerEU-funded project to strengthen research and innovation in Alzheimer's diagnostics and introduce novel technologies into clinical management. Partners from Czech Republic and Slovakia.
• ERA4HEALTH PartnershipcoreStrategic or Co-development PartnerEuropean partnership fostering ERA for health research from November 2022 to June 2034. Coordinated by prof. MUDr. Imrich Richard, DrSc. with 20+ partner countries.
• Multiple COST ActionscoreStrategic or Co-development PartnerParticipation in multiple COST (European Cooperation in Science and Technology) Actions including AdResCanCER, TEAR-Precision, NanoBio4Can, SIGMA-1EUROPE, INFOGUT, Precision-BTC-Ne, REACH, ANGELA, IMMUNO-model, PRAGMATICK, TRANSPAN, TRANSLACORE, DYNALIFE, NETSKINMODELS, WIMANET, and others.
• TEIDe (Tailored Exercise Interventions for Dementia Prevention)coreStrategic or Co-development PartnerHorizon Europe project on dementia prevention through exercise interventions, coordinated by prof. MUDr. Barbara Ukropcová, PhD. with partners from 8 countries including USA, Canada, Germany, Italy, Norway, Romania, and Spain.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Max Delbrück Center for Molecular Medicine (MDC): Berlin-based Helmholtz biomedical research center integrating multiple institutes across systems biology, cancer, cardiovascular, and neuroscience research. Larger and better funded but comparable in multi-disciplinary biomedical integration.
• Helmholtz Centre for Infection Research (HZI): Large German federally funded infection-research center with BSL3/BSL4 capabilities, virology programs, and GMP translational infrastructure. Broader in scope and scale but comparable on biomedical, infectious-disease, and translational dimensions.
• Karolinska Institutet: Sweden's premier medical university with strong translational research, biomedical infrastructure, and international EU-project participation. Comparable on biomedical research, doctoral training, and EU-grant participation but at much larger scale.
• European Molecular Biology Laboratory (EMBL): Intergovernmental research organization for molecular life sciences with sites across Europe. Comparable on biomedical research mission, EU-grant participation, and bioinformatics/translational capability, though with much broader geographic reach and larger budget.
• Institut Pasteur: Internationally renowned French biomedical research foundation with deep virology and infectious-disease capabilities, including high-containment laboratories. Overlaps with BMC SAV's virology and BSL3 mission at a much larger global scale.

Emerging players

• International Centre for Genetic Engineering and Biotechnology (ICGEB): Tri-mission UN research organization operating biotechnology research centers in Italy, India, and South Africa. Comparable in biomedical R&D mission and international scientific collaboration model, though with a different funding structure.
• Centre for Genomic Regulation (CRG): Spanish biomedical research institute combining genomics, bioinformatics, and cell biology research. Comparable on multi-disciplinary biomedical integration, bioinformatics capability, and EU-funded international collaboration model.

Direct peers

• Czech Academy of Sciences – Institute of Microbiology: A neighboring Central European Academy-of-Sciences biomedical research institute with similar virology, immunology, and microbiology focus. Directly comparable as a publicly funded national biomedical research institute with similar scale and mission.
• Polish Academy of Sciences – Institute of Biochemistry and Biophysics: Polish Academy institute covering molecular biology, genomics, and biomedical research with similar scale and public-institution funding model. Comparable as a national-level Central European biomedical research institute under an Academy-of-Sciences umbrella.
• Hungarian Research Network (HUN-REN): Hungary's national public research network consolidating multiple research institutes under a single governance structure. Directly comparable to BMC SAV as a Central European national-level public research institution integrating multiple life-science and biomedical disciplines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Biomedical-Research-Center-of-the-Slovak-Academy-of-Sciences-1841679899470314
• LinkedInlinkedin.com/company/biomedical-research-center-of-the-slovak-academy-of-sciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biomedical Research Center of the Slovak Academy of Sciences